#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma Neuronal ceroid lipofuscinosis Facioscapulohumeral muscular dystrophy Neuroendocrine carcinoma Obesity Neuroendocrine tumour of the lung Vaginal cancer Paraganglion neoplasm Systemic lupus erythematosus Inborn error of metabolism Cholangiocarcinoma Immune-mediated myasthenia gravis Polycystic liver disease Breast angiosarcoma Solitary fibrous tumour More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX – Basic Information Ehlers-Danlos syndrome – Basic Information Synovial sarcoma recurrent – Basic Information Noonan syndrome Congenital nephrogenic diabetes insipidus – Trials in Disease Haemophilia A with anti factor VIII – Life with Disease Retinoblastoma – Diagnostics Congenital hypotransferrinaemia Urea cycle disorder Waldenstrom’s macroglobulinaemia recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Piperacillin Monohydrate Revumenib Rilzabrutinib Cd19-Car_Lenti_Allo Fluoxetine Istradefylline CANNABINOL PHENTOLAMINE MESILATE Fluvastatin Cocarboxylase Tetrahydrate HUMAN COAGULATION FACTOR XIII Elacestrant Dihydrochloride Bi-1910 Lazertinib Duloxetine Alglucosidase Alfa Falbikitug NORGESTIMATE Levamlodipine Succinate Bevacizumab Zirconium Zr-89 More therapies…

    Learn about Your Condition

    Pulmonary venous thrombosis Hyperparathyroidism primary Paraganglion neoplasm Arteriovenous malformation Klinefelter's syndrome Rosai-Dorfman syndrome Hypersensitivity Coronary artery occlusion Hodgkin's disease recurrent Red blood cell abnormality Osteosarcoma Viral infection Pulmonary alveolar haemorrhage Obstructive pancreatitis Drug use disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Safety and early effectiveness study of VG801 subretinal injection in patients with ABCA4 mutation-associated retinal dystrophy

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • VG801-1
    • VG801-2
    Germany

  • Study to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • HUMANISED IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST THYMIC STROMAL LYMPHOPOIETIN
    Czechia Germany Poland

  • Study of intraperitoneal fosfomycin, metronidazole and molgramostim treatment in patients with multi-quadrant peritonitis during abdominal surgery

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Fosfomycin
    • Molgramostim
    • Metronidazole
    Denmark

  • Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Img-007
    Czechia Germany Hungary Poland Spain

  • Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • INSULIN DETEMIR
    • Insulin Icodec
    • INSULIN DEGLUDEC
    Germany Italy

  • Study of dronabinol and cannabidiol oral solution for symptom relief in advanced cancer patients receiving opioid treatment

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Cancer pain
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Italy
Previous Page
1 … 770 771 772 773 774 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!